These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3527111

  • 1. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Hesse UJ, Fryd DS, Chatterjee SN, Simmons RL, Sutherland DE, Najarian JS.
    Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
    [Abstract] [Full Text] [Related]

  • 2. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 3. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE.
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [Abstract] [Full Text] [Related]

  • 4. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
    Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, Ascher NL, Najarian JS.
    Am J Kidney Dis; 1984 May; 3(6):456-61. PubMed ID: 6372449
    [No Abstract] [Full Text] [Related]

  • 5. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin.
    Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS.
    Transplantation; 1987 Dec; 44(6):775-8. PubMed ID: 3321586
    [Abstract] [Full Text] [Related]

  • 10. Incidence and treatment of candida esophagitis in patients undergoing renal transplantation. Data from the Minnesota prospective randomized trial of cyclosporine versus antilymphocyte globulin-azathioprine.
    Frick T, Fryd DS, Goodale RL, Simmons RL, Sutherland DE, Najarian JS.
    Am J Surg; 1988 Feb; 155(2):311-3. PubMed ID: 3277475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR, Hastillo A, Goldman MH, Szentpetery S, Wolfgang TC, Mohanakumar T, Katz MR, Rider S, Hanrahan J, Lower RR.
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [Abstract] [Full Text] [Related]

  • 15. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL, Venkatachalam KK, Oh HK, Dienst S, Levin NW.
    Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
    [Abstract] [Full Text] [Related]

  • 16. Comparison of antilymphocyte globulin and continuous i.v. cyclosporine A as induction immunosuppression for cadaver kidney transplants: a prospective randomized study.
    Belitsky P, MacDonald AS, Cohen AD, Crocker J, Hirsch D, Jindal K, Lawen J.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):999-1000. PubMed ID: 1989359
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
    Hodge EE, Banowsky LH, Novick AC, Lewis RM, Streem SB, Steinmuller DR, Holzmann JJ, McFarlin L, Graneto DE.
    J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation.
    Cantarovich D, Karam G, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Le Normand L, Soulillou JP.
    Kidney Int; 1998 Oct; 54(4):1351-6. PubMed ID: 9767555
    [Abstract] [Full Text] [Related]

  • 20. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA, Mayes JT, Moritz CE, Hricik DE.
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.